نتایج جستجو برای: thiopurine methyl transferase

تعداد نتایج: 139474  

2013
Sofie Haglund Sven Almer Curt Peterson Jan Söderman

BACKGROUND AND AIMS Thiopurines are effective to induce and maintain remission in inflammatory bowel disease (IBD). The methyl thioinosine monophosphate (meTIMP)/6-thioguanine nucleotide (6-TGN) concentration ratio has been associated with drug efficacy. Here we explored the molecular basis of differences in metabolite profiles and in relation to disease activity. METHODS Transcriptional prof...

Journal: :Journal of Crohn's & colitis 2014
D R Wong M Pierik M L Seinen A A van Bodegraven L P L Gilissen P Bus J A Bakker A A M Masclee C Neef L G J B Engels P M Hooymans

BACKGROUND AND AIMS A drug interaction between infliximab and azathioprine has previously been reported in Crohn's disease patients: the concentration of the main active thiopurine metabolites, the 6-thioguanine nucleotides (6-TGN), increased 1-3 weeks after the first infliximab infusion by 50% compared to baseline. The aim of this prospective study was to determine the effect of adalimumab on ...

2017
Brigitte Moreau Pierre Clement Yves Theoret Ernest G. Seidman

Background Thiopurines, azathioprine (AZA) and 6-mercaptopurine (6-MP) are common maintenance medications for inflammatory bowel disease (IBD). Excessive methylation via thiopurine methyltransferase (TPMT) frequently causes therapeutic failure. Allopurinol reduces excessive 6-methyl-mercaptopurine (6-MMP) while enhancing 6-thioguanine (6-TGN) levels. The aim of this study was to evaluate clinic...

Journal: :Archives of Disease in Childhood 2023

Aim Paediatric inflammatory bowel disease (IBD) accounts for 7–22% of IBD cases globally and there is evidence to suggest that the incidence rising. 1 The aims therapy in paediatric are relieve symptoms, optimize growth, improve quality life while minimizing drug toxicity reducing risk complications without surgery. Treatment involves two main steps, inducing remission maintaining remission. Th...

Journal: :Journal of bacteriology 2002
Lionel Ranjard Claire Prigent-Combaret Sylvie Nazaret Benoit Cournoyer

Escherichia coli cells expressing the tpm gene encoding the bacterial thiopurine methyltransferase (bTPMT) are shown to methylate selenite and (methyl)selenocysteine into dimethylselenide (DMSe) and dimethyldiselenide (DMDSe). E. coli cells expressing tpm from a gene library cosmid clone (harboring a Pseudomonas syringae insert of about 20 kb) also methylated selenate into DMSe and DMDSe. bTPMT...

Journal: :Applied and environmental microbiology 2003
Lionel Ranjard Sylvie Nazaret Benoit Cournoyer

Involvement of the bacterial thiopurine methyltransferase (bTPMT) in natural selenium methylation by freshwater was investigated. A freshwater environment that had no known selenium contamination but exhibited reproducible emission of dimethyl selenide (DMSe) or dimethyl diselenide (DMDSe) when it was supplemented with an organic form of selenium [(methyl)selenocysteine] or an inorganic form of...

2011
Sally A. Coulthard Christopher P.F. Redfern Svante Vikingsson Malin Lindqvist-Appell Karin Skoglund Ingrid Jakobsen-Falk Andrew G. Hall Gordon A. Taylor Linda A. Hogarth

The thiopurines, 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG), are used in the treatment of leukemia. Incorporation of deoxythioguanosine nucleotides (dG) into the DNA of thiopurine-treated cells causes cell death, but there is also evidence that thiopurine metabolites, particularly the 6-MP metabolite methylthioinosinemonophosphate (MeTIMP), inhibit de novo purine synthesis (DNPS). The tox...

Journal: :Molecular cancer therapeutics 2011
Sally A Coulthard Christopher P F Redfern Svante Vikingsson Malin Lindqvist-Appell Karin Skoglund Ingrid Jakobsen-Falk Andrew G Hall Gordon A Taylor Linda A Hogarth

The thiopurines, 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG), are used in the treatment of leukemia. Incorporation of deoxythioguanosine nucleotides (dG(s)) into the DNA of thiopurine-treated cells causes cell death, but there is also evidence that thiopurine metabolites, particularly the 6-MP metabolite methylthioinosine monophosphate (MeTIMP), inhibit de novo purine synthesis (DNPS). The...

Journal: :European journal of medical research 2005
J Glas H-P Török J Daczo L Tonenchi M Folwaczny Christian Folwaczny

INTRODUCTION Azathioprine has variable efficacy in inflammatory bowel disease. Previous studies suggested that either neutropenia, an increase in the mean corpuscular volume, the assessment of thiopurine methyl-transferase activity or erythrocyte 6-thioguanine values might predict the treatment response. However, due to the conflicting results of the preceding studies there are yet no establish...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید